REGENERON PHARMACEUTICALS, INC.
REGNSEC CIK 872589Price charts ↗
Writing the earnings story…
Financials
Revenue+19.0% YoY
$3.61B
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Net Income-10.1% YoY
$727.2M
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
EPS (diluted)-7.2% YoY
$6.75
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Gross Margin
—
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
| Quarter ending | Revenue | Net income | EPS |
|---|---|---|---|
| Mar 2026 | $3.61B | $727.2M | $6.75 |
| Sep 2025 | $3.75B | $1.46B | $13.62 |
| Jun 2025 | $3.68B | $1.39B | $12.81 |
| Mar 2025 | $3.03B | $808.7M | $7.27 |
| Sep 2024 | $3.72B | $1.34B | $11.54 |
| Jun 2024 | $3.55B | $1.43B | $12.41 |
| Mar 2024 | $3.15B | $722.0M | $6.27 |
| Sep 2023 | $3.36B | $1.01B | $8.89 |
Annual revenue
FY21FY22FY23FY24FY25
Source filings
Download the original reports from the SEC. A 10-Q is the quarterly update; a 10-K is the detailed annual report.
Quarterly report (10-Q)Filed 2026-04-29 · period ending 2026-03-31Open ↗Annual report (10-K)Filed 2026-02-04 · period ending 2025-12-31Open ↗Quarterly report (10-Q)Filed 2025-10-28 · period ending 2025-09-30Open ↗Quarterly report (10-Q)Filed 2025-08-01 · period ending 2025-06-30Open ↗Quarterly report (10-Q)Filed 2025-04-29 · period ending 2025-03-31Open ↗Annual report (10-K)Filed 2025-02-05 · period ending 2024-12-31Open ↗Quarterly report (10-Q)Filed 2024-10-31 · period ending 2024-09-30Open ↗Quarterly report (10-Q)Filed 2024-08-01 · period ending 2024-06-30Open ↗
Glossary
- Revenue
- Net income
- EPS
- Gross margin
- Net margin
- Fiscal year
Hover any underlined term for its definition.